Results 41 to 50 of about 5,252,361 (312)

Barriers and facilitators to implementing an evidence-based woman-focused intervention in South African health services

BMC Health Services Research, 2017
Background Since the beginning of the HIV epidemic, numerous behavior change, risk-reduction, and biomedical interventions have been developed and tested. While some of these interventions have shown to be efficacious in randomized trials, it often takes
Brittni N. Howard, Richard Van Dorn, Bronwyn J. Myers, William A. Zule, Felicia A. Browne, Tara Carney, Wendee M. Wechsberg   +6 more
doaj   +1 more source

Trends in use of antipsychotics in Germany 2014–2024: a nationwide population-based study

BMC Psychiatry
Background Antipsychotic medication (APM) use in children and adolescents in Germany increased over decades. However, contemporary data across all age groups is lacking. We aimed to analyze outpatient APM use across all age groups in Germany between 2014
Andrea Espinosa Daudí, Marita Kieble, Martin Schulz   +2 more
doaj   +1 more source

Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol

BMC Public Health, 2017
Background More than half of persons living with HIV (PLWH) in the United States are insufficiently engaged in HIV primary care and not taking antiretroviral therapy (ART), mainly African Americans/Blacks and Hispanics.
Marya Viorst Gwadz, Linda M. Collins, Charles M. Cleland, Noelle R. Leonard, Leo Wilton, Monica Gandhi, R. Scott Braithwaite, David C. Perlman, Alexandra Kutnick, Amanda S. Ritchie   +9 more
doaj   +1 more source

Medication Errors Associated With Adverse Drug Reactions in Iran (2015-2017): A P-Method Approach [PDF]

International Journal of Health Policy and Management, 2018
Medication errors are the second most common cause of adverse patient safety incidents and the single most common preventable cause of adverse events in medical practice.
Zahra Karimian, Mehrnaz Kheirandish, Naghmeh Javidnikou, Gholamreza Asghari, Fariba Ahmadizar, Rassoul Dinarvand   +5 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie, Kara A. Gray‐Burrows, Peter F. Day, Bob Phillips, Carl A. Thompson   +4 more
wiley   +1 more source

Drug-drug interaction prediction using PASS

SAR and QSAR in Environmental Research, 2019
Simultaneous use of the drugs may lead to undesirable Drug-Drug Interactions (DDIs) in the human body. Many DDIs are associated with changes in drug metabolism that performed by Drug-Metabolizing Enzymes (DMEs). In this case, DDI manifests itself as a result of the effect of one drug on the biotransformation of other drug(s), its slowing down (in the ...
A.V. Dmitriev, D.A. Filimonov, A.V. Rudik, P.V. Pogodin, D.A. Karasev, A.A. Lagunin, V.V. Poroikov   +6 more
openaire   +2 more sources

Market Analysis of Plant-based Drugs C. The Cannabis Market [PDF]

, 2017
An estimated quarter of a billion people, or around 5 per cent of the global adult population, used drugs at least once in 2015. Even more worrisome is the fact that about 29.5 million of those drug users, or 0.6 per cent of the global adult population ...

core  

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate.
Negar Shavandi, Paula D. Robinson, Shana Jacobs, L. Lee Dupuis, the International Pediatric Dexamethasone Panel, Sameer Bakhshi, Tiene Bauters, Eva Brack, Simone Cesaro, Claire Fosbrook, Jason Freedman, Tamara MacDonald, Eloise Neumann, Venkatraman Radhakrishnan, Rod Rassekh, Florian Slimano, Johnathan Soggee, Joel Thompson, Marianne van de Wetering, Milena Villarroel, Jasper Wong   +20 more
wiley   +1 more source

Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024

Harm Reduction Journal
Background Xylazine has emerged as a major component of the unregulated opioid supply in several jurisdictions across the United States. However, the extent of xylazine in local drug supplies is unknown.
Leonardo A. Dominguez Gomez, Yarelix Estrada, Jeffery Sauer, Izza Zaidi, Andrew J. Trinidad, Hannah Helmy, Alex Harocopos   +6 more
doaj   +1 more source